1. Market Research
  2. > Biotechnology Market Trends
  3. > Biopharmaceutical

Biopharmaceutical Sector: Get Market Research and Figures

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
10 votes

Global Biopharmaceutical Industry

The global biopharmaceutical industry (a part of the biotechnology market) is currently worth over $145 billion, according to research conducted by BioPlan Associates. The industry should exceed $167 billion in 2015, says IMARC. 

Biopharmaceuticals are used in the prevention and treatment of disease, and there are over 300 approved biopharmaceuticals on the market, with many in clinical development yet to come. The market has benefited from the need for pharmaceutical manufacturers to boost output, but it has a high risk factor, with only three out of 10 drugs that pass to the clinical phase receiving market clearance.

Cost containment and biosimilar entry in developed markets continue to see slow growth, but the market should expand thanks to biopharmaceutical capacity to outperform traditional small molecule drugs. Over the coming five-year period, factors such as development of emerging markets and a rich late-stage pipeline are expected to fuel growth.

Key Biopharmaceutical Market Segments

The world biosimilar market is expected to record yearly growth in excess of 50% between 2010 and 2015, reports RNCOS. Market growth is being driven by factors such as costly drugs, high pharmaceutical expenditure and a global aging population. Market expansion will be further fuelled by expiring patents and the increasing cost of drugs. Sandoz is the leading company operating in the global biosimilars market, recording the highest sales. Teva and Hospira are developing a biosimilar product range.

The global enzyme market is expected to exceed $7.5 billion in 2015, reports Freedonia, and it should surpass yearly growth of 5%. The fastest rate of growth will be recorded in smaller markets such as the Africa/Middle East region, and Central and South America. Asia-Pacific is expected to record strong growth, while the EU and North America are forecast to record below-average growth.

The global protein therapeutics market is forecast to see yearly growth of 13% between 2012 and 2014, reports RNCOS. Increased investment and the introduction of new protein therapeutics will fuel market  expansion. Protein therapeutics have been recording a high rate of growth in recent years, vital to the treatment of many diseases. Protein therapeutics are particularly efficient due to their targeted approach, which allows the treatment of disease with little or no negative impact on healthy organs. Protein therapies are necessary in a healthcare landscape, witnessing rapidly rising rates of chronic illnesses like cardiovascular diseases, diabetes and cancer.

The cancer monoclonal antibodies market is expected to grow at a yearly rate in excess of 5% between 2012 and 2015, according to RNCOS. Cancer monoclonal antibodies are used to treat tumors with a high degree of specification. The market is driven by increasing prevalence of cancer and the need for more innovation research. The industry is witnessing rising consolidation.



You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+33 4 37 65 17 06

1-10 of about 1000 reports

Global Biopharmaceutical Industry - Forecast

  • January 2017
    15 pages
  • Biopharmaceutic...  

  • World  


View report >

Biopharmaceutical Industry in the US - Forecast

  • September 2017
    12 pages
  • Biopharmaceutic...  

  • United States  

View report >

Biopharmaceutical Industry in Ireland and Europe

  • February 2017
    16 pages
  • Biopharmaceutic...  

  • Ireland  



View report >

Biopharmaceutical Markets in Asia

  • January 2016
    8 pages
  • Biopharmaceutic...  


  • Asia  

View report >

Biopharmaceutical Industry in Japan

  • May 2016
    8 pages
  • Biopharmaceutic...  

  • Japan  

    United States  


View report >

Biopharmaceutical Industry in Germany

  • December 2016
    13 pages
  • Biopharmaceutic...  

  • Germany  


View report >

Biopharmaceutical Industry in the UK

  • January 2016
    64 pages
  • Biopharmaceutic...  

    Life Sciences  

  • United Kingdom  


View report >

Biopharmaceutical Industry in Canada - Forecast

  • November 2015
    19 pages
  • Biopharmaceutic...  

    Factor VIII  

  • Canada  

View report >

Biopharmaceutical Markets in Brazil - Forecast

  • May 2016
    5 pages
  • Biopharmaceutic...  

  • Brazil  


    South America  

View report >

Search in Biopharmaceutical Industry (About 1000 reports)
Parent industry: Biotechnology
Related industries: Biological Therapy, Biomaterial, Genetically Modified Organism, Genomics

About 500 reports

Purchase Reports From Reputable Market Research Publishers
(From € 68 - € 9995)

OpportunityAnalyzer: Growth Hormone Deficiency - Opportunity Analysis and Forecasts to 2026

  • € 9995
  • Industry report
  • May 2017
  • by GlobalData

OpportunityAnalyzer: Growth Hormone Deficiency - Opportunity Analysis and Forecasts to 2026 Summary Growth hormone deficiency (GHD) is a rare endocrine disorder characterized by inadequate secretion of ...

Pharmapoint: Rheumatoid Arthritis - Global Drug Forecas ...

February 2017 € 9995

Pharmapoint: Ulcerative Colitis - Global Drug Forecast ...

January 2017 € 9995

Pharmapoint: Psoriatic Arthritis - Global Drug Forecast ...

December 2016 € 9995

Rheumatoid Arthritis: Payer Insight 2016

November 2016 € 7595

Psoriatic Arthritis Pricing, Reimbursement, And Access

June 2016 € 6818

Biosimilars Market Access In The U.s.

March 2017 € 6818

Biosimilars Market Access In Psoriasis

March 2017 € 6818

World Enzymes Market

June 2016 € 5727

Single-use Bioprocessing Market By Product, Application ...

October 2016 € 5650

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.